Ratings Lincoln National Corporation

Equities

LNC

US5341871094

Market Closed - Nyse Other stock markets 04:00:02 2024-04-15 pm EDT			5-day change	1st Jan Change
27.88 ^USD	-1.41%		-9.74%	+3.37%

Apr. 11	Wells Fargo Adjusts Price Target on Lincoln National to $28 From $26, Keeps Equalweight Rating	MT
Apr. 11	Evercore ISI Raises Price Target on Lincoln National to $35 From $33, Maintains In-Line Rating	MT

Summary

Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
The company shows low valuation levels, with an enterprise value at 0.58 times its sales.
The company's share price in relation to its net book value makes it look relatively cheap.
The company has a low valuation given the cash flows generated by its activity.
The company is one of the best yield companies with high dividend expectations.
Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Life & Health Insurance

	1st Jan change	Capi.	ESG Refinitiv
LINCOLN NATIONAL CORPORATION	+3.37%	4.74B	B+
AXA	+14.68%	79.11B	B-
AFLAC INCORPORATED	-2.70%	46.19B	B
MANULIFE FINANCIAL CORPORATION	+8.20%	41.46B	B+
PRUDENTIAL FINANCIAL, INC.	+4.48%	38.94B	B+
GENERALI	+18.61%	38.2B	B
SUN LIFE FINANCIAL INC.	+1.79%	29.61B	B
GREAT-WEST LIFECO INC.	-8.30%	27.26B	B-
PRUDENTIAL PLC	-20.02%	24.22B	A-
DAI-ICHI LIFE HOLDINGS, INC.	+17.78%	22.38B	B

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes